Status:
COMPLETED
The New Executive and Appendix Template (NEAT) Study
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
National Center for Advancing Translational Sciences (NCATS)
Conditions:
Comprehension
Informed Consent
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
There is evidence that the current design and content provided by most biomedical research informed consent documents do not consistently meet the expectations researchers place on them to effectively...
Detailed Description
The importance of informed consent is to ensure that participants in clinical research are provided the opportunity to make autonomous choices is a paramount ethical premise in human research. The eff...
Eligibility Criteria
Inclusion
- Individuals who are eligible for the ARIC study, with which this pilot study is cooperating.
Exclusion
- Any individuals not eligible for the ARIC study.
Key Trial Info
Start Date :
April 4 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 23 2017
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT03419832
Start Date
April 4 2017
End Date
May 23 2017
Last Update
October 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, United States, 27157